Targeted learning in real-world comparative effectiveness research with time-varying interventions

被引:31
|
作者
Neugebauer, Romain [1 ]
Schmittdiel, Julie A. [1 ]
van der Laan, Mark J. [2 ]
机构
[1] Kaiser Permanente No Calif, Div Res, Oakland, CA 94611 USA
[2] Univ Calif Berkeley, Sch Publ Hlth, Div Biostat, Berkeley, CA 94720 USA
基金
美国医疗保健研究与质量局;
关键词
targeted learning; marginal structural model; inverse probability weighting; efficiency gain; comparative effectiveness; diabetes; AMERICAN-DIABETES-ASSOCIATION; MARGINAL STRUCTURAL MODELS; DEMYSTIFYING DOUBLE ROBUSTNESS; CAUSAL INFERENCE; GLUCOSE-CONTROL; ALTERNATIVE STRATEGIES; ANTIRETROVIRAL THERAPY; EUROPEAN-ASSOCIATION; CONSENSUS STATEMENT; ADJUSTMENT;
D O I
10.1002/sim.6099
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In comparative effectiveness research (CER), often the aim is to contrast survival outcomes between exposure groups defined by time-varying interventions. With observational data, standard regression analyses (e.g., Cox modeling) cannot account for time-dependent confounders on causal pathways between exposures and outcome nor for time-dependent selection bias that may arise from informative right censoring. Inverse probability weighting (IPW) estimation to fit marginal structural models (MSMs) has commonly been applied to properly adjust for these expected sources of bias in real-world observational studies. We describe the application and performance of an alternate estimation approach in such a study. The approach is based on the recently proposed targeted learning methodology and consists in targeted minimum loss-based estimation (TMLE) with super learning (SL) within a nonparametric MSM. The evaluation is based on the analysis of electronic health record data with both IPW estimation and TMLE to contrast cumulative risks under four more or less aggressive strategies for treatment intensification in adults with type 2 diabetes already on 2+ oral agents or basal insulin. Results from randomized experiments provide a surrogate gold standard to validate confounding and selection bias adjustment. Bootstrapping is used to validate analytic estimation of standard errors. This application does the following: (1) establishes the feasibility of TMLE in real-world CER based on large healthcare databases; (2) provides evidence of proper confounding and selection bias adjustment with TMLE and SL; and (3) motivates their application for improving estimation efficiency. Claims are reinforced with a simulation study that also illustrates the double-robustness property of TMLE. Copyright (c) 2014 John Wiley & Sons, Ltd.
引用
收藏
页码:2480 / 2520
页数:41
相关论文
共 50 条
  • [1] Real-World Effectiveness of Pharmaceutical Smoking Cessation Aids: Time-Varying Effects
    Chaiton, Michael
    Diemert, Lori M.
    Bondy, Susan J.
    Cohen, Joanna E.
    Fung, Michael D.
    Zhang, Bo R.
    Ferrence, Roberta G.
    [J]. NICOTINE & TOBACCO RESEARCH, 2020, 22 (04) : 506 - 511
  • [2] High-dimensional propensity score algorithm in comparative effectiveness research with time-varying interventions
    Neugebauer, Romain
    Schmittdiel, Julie A.
    Zhu, Zheng
    Rassen, Jeremy A.
    Seeger, John D.
    Schneeweiss, Sebastian
    [J]. STATISTICS IN MEDICINE, 2015, 34 (05) : 753 - 781
  • [3] Identifying surrogate markers in real-world comparative effectiveness research
    Han, Larry
    Wang, Xuan
    Cai, Tianxi
    [J]. STATISTICS IN MEDICINE, 2022, 41 (26) : 5290 - 5304
  • [4] Comparative Effectiveness and Real-World Evidence
    Leonard, Daniel T.
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2010, 16 (06): : 410 - 411
  • [5] Time-Varying Constraints and Other Practical Problems in Real-World Scheduling Applications
    Mohais, Arvind
    Ibrahimov, Maksud
    Schellenberg, Sven
    Wagner, Neal
    Michalewicz, Zbigniew
    [J]. 2010 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), 2010,
  • [6] Time-varying propensity score matching as a method to balance baseline covariates and calendar time effects in a real-world effectiveness analysis
    DuVall, Scott L.
    Lynch, Julie A.
    Alba, Patrick R.
    Suchard, Marc A.
    Matheny, Michael E.
    Kamauu, Aaron
    Shields, Amanda
    Taylor, Sylvia
    Talarico, Carla A.
    Venkatesan, Sudhir
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 285 - 286
  • [7] Real-World Impact of Comparative Effectiveness Research Findings on Clinical Practice
    Gibson, Teresa B.
    Ehrlich, Emily D.
    Graff, Jennifer
    Dubois, Robert
    Farr, Amanda M.
    Chernew, Michael
    Fendrick, A. Mark
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2014, 20 (06): : E208 - E220
  • [8] Addressing missing data in the estimation of time-varying treatments in comparative effectiveness research
    Segura-Buisan, Juan
    Leyrat, Clemence
    Gomes, Manuel
    [J]. STATISTICS IN MEDICINE, 2023, 42 (27) : 5025 - 5038
  • [9] Building trust in real-world evidence and comparative effectiveness research: the need for transparency
    White, Richard
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2017, 6 (01) : 5 - 7
  • [10] "Ten Commandments" for Conducting Comparative Effectiveness Research Using "Real-World Data"
    Willke, Richard J.
    Mullins, C. Daniel
    [J]. JOURNAL OF MANAGED CARE PHARMACY, 2011, 17 (09): : S10 - S15